Report Detail

Request for Sample of this report

Other Global Gene Therapy for Neurodegenerative Diseases Market 2023 by Company, Regions, Type and Application, Forecast to 2029

  • RnM4556081
    • |
  • 17 September, 2023
    • |
  • Global
    • |
  • 100 Pages
    • |
  • GIR (Global Info Research)
    • |
  • Other

According to our (Global Info Research) latest study, the global Gene Therapy for Neurodegenerative Diseases market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period.
The Global Info Research report includes an overview of the development of the Gene Therapy for Neurodegenerative Diseases industry chain, the market status of Hospitals and Clinics (Gene Replacement Therapy, Gene Silencing Therapy), Research Institutions (Gene Replacement Therapy, Gene Silencing Therapy), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Gene Therapy for Neurodegenerative Diseases.
Regionally, the report analyzes the Gene Therapy for Neurodegenerative Diseases markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Gene Therapy for Neurodegenerative Diseases market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Gene Therapy for Neurodegenerative Diseases market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Gene Therapy for Neurodegenerative Diseases industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., Gene Replacement Therapy, Gene Silencing Therapy).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Gene Therapy for Neurodegenerative Diseases market.
Regional Analysis: The report involves examining the Gene Therapy for Neurodegenerative Diseases market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Gene Therapy for Neurodegenerative Diseases market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Gene Therapy for Neurodegenerative Diseases:
Company Analysis: Report covers individual Gene Therapy for Neurodegenerative Diseases players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Gene Therapy for Neurodegenerative Diseases This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Hospitals and Clinics, Research Institutions).
Technology Analysis: Report covers specific technologies relevant to Gene Therapy for Neurodegenerative Diseases. It assesses the current state, advancements, and potential future developments in Gene Therapy for Neurodegenerative Diseases areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Gene Therapy for Neurodegenerative Diseases market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Gene Therapy for Neurodegenerative Diseases market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
Gene Replacement Therapy
Gene Silencing Therapy
Gene Editing Therapy
Enzyme Replacement Therapy
Market segment by Application
Hospitals and Clinics
Research Institutions
Biotechnology Companies
Others
Market segment by players, this report covers
Voyager Therapeutics
Uniqure N.V.
Axovant Gene Therapies
Novartis Ag
Amicus Therapeutics
Regenxbio Inc.
Sarepta Therapeutics
Gensight Biologics
Krystal Biotech
Avexis
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Gene Therapy for Neurodegenerative Diseases product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Gene Therapy for Neurodegenerative Diseases, with revenue, gross margin and global market share of Gene Therapy for Neurodegenerative Diseases from 2018 to 2023.
Chapter 3, the Gene Therapy for Neurodegenerative Diseases competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Gene Therapy for Neurodegenerative Diseases market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Gene Therapy for Neurodegenerative Diseases.
Chapter 13, to describe Gene Therapy for Neurodegenerative Diseases research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope of Gene Therapy for Neurodegenerative Diseases
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Classification of Gene Therapy for Neurodegenerative Diseases by Type
    • 1.3.1 Overview: Global Gene Therapy for Neurodegenerative Diseases Market Size by Type: 2018 Versus 2022 Versus 2029
    • 1.3.2 Global Gene Therapy for Neurodegenerative Diseases Consumption Value Market Share by Type in 2022
    • 1.3.3 Gene Replacement Therapy
    • 1.3.4 Gene Silencing Therapy
    • 1.3.5 Gene Editing Therapy
    • 1.3.6 Enzyme Replacement Therapy
  • 1.4 Global Gene Therapy for Neurodegenerative Diseases Market by Application
    • 1.4.1 Overview: Global Gene Therapy for Neurodegenerative Diseases Market Size by Application: 2018 Versus 2022 Versus 2029
    • 1.4.2 Hospitals and Clinics
    • 1.4.3 Research Institutions
    • 1.4.4 Biotechnology Companies
    • 1.4.5 Others
  • 1.5 Global Gene Therapy for Neurodegenerative Diseases Market Size & Forecast
  • 1.6 Global Gene Therapy for Neurodegenerative Diseases Market Size and Forecast by Region
    • 1.6.1 Global Gene Therapy for Neurodegenerative Diseases Market Size by Region: 2018 VS 2022 VS 2029
    • 1.6.2 Global Gene Therapy for Neurodegenerative Diseases Market Size by Region, (2018-2029)
    • 1.6.3 North America Gene Therapy for Neurodegenerative Diseases Market Size and Prospect (2018-2029)
    • 1.6.4 Europe Gene Therapy for Neurodegenerative Diseases Market Size and Prospect (2018-2029)
    • 1.6.5 Asia-Pacific Gene Therapy for Neurodegenerative Diseases Market Size and Prospect (2018-2029)
    • 1.6.6 South America Gene Therapy for Neurodegenerative Diseases Market Size and Prospect (2018-2029)
    • 1.6.7 Middle East and Africa Gene Therapy for Neurodegenerative Diseases Market Size and Prospect (2018-2029)

2 Company Profiles

  • 2.1 Voyager Therapeutics
    • 2.1.1 Voyager Therapeutics Details
    • 2.1.2 Voyager Therapeutics Major Business
    • 2.1.3 Voyager Therapeutics Gene Therapy for Neurodegenerative Diseases Product and Solutions
    • 2.1.4 Voyager Therapeutics Gene Therapy for Neurodegenerative Diseases Revenue, Gross Margin and Market Share (2018-2023)
    • 2.1.5 Voyager Therapeutics Recent Developments and Future Plans
  • 2.2 Uniqure N.V.
    • 2.2.1 Uniqure N.V. Details
    • 2.2.2 Uniqure N.V. Major Business
    • 2.2.3 Uniqure N.V. Gene Therapy for Neurodegenerative Diseases Product and Solutions
    • 2.2.4 Uniqure N.V. Gene Therapy for Neurodegenerative Diseases Revenue, Gross Margin and Market Share (2018-2023)
    • 2.2.5 Uniqure N.V. Recent Developments and Future Plans
  • 2.3 Axovant Gene Therapies
    • 2.3.1 Axovant Gene Therapies Details
    • 2.3.2 Axovant Gene Therapies Major Business
    • 2.3.3 Axovant Gene Therapies Gene Therapy for Neurodegenerative Diseases Product and Solutions
    • 2.3.4 Axovant Gene Therapies Gene Therapy for Neurodegenerative Diseases Revenue, Gross Margin and Market Share (2018-2023)
    • 2.3.5 Axovant Gene Therapies Recent Developments and Future Plans
  • 2.4 Novartis Ag
    • 2.4.1 Novartis Ag Details
    • 2.4.2 Novartis Ag Major Business
    • 2.4.3 Novartis Ag Gene Therapy for Neurodegenerative Diseases Product and Solutions
    • 2.4.4 Novartis Ag Gene Therapy for Neurodegenerative Diseases Revenue, Gross Margin and Market Share (2018-2023)
    • 2.4.5 Novartis Ag Recent Developments and Future Plans
  • 2.5 Amicus Therapeutics
    • 2.5.1 Amicus Therapeutics Details
    • 2.5.2 Amicus Therapeutics Major Business
    • 2.5.3 Amicus Therapeutics Gene Therapy for Neurodegenerative Diseases Product and Solutions
    • 2.5.4 Amicus Therapeutics Gene Therapy for Neurodegenerative Diseases Revenue, Gross Margin and Market Share (2018-2023)
    • 2.5.5 Amicus Therapeutics Recent Developments and Future Plans
  • 2.6 Regenxbio Inc.
    • 2.6.1 Regenxbio Inc. Details
    • 2.6.2 Regenxbio Inc. Major Business
    • 2.6.3 Regenxbio Inc. Gene Therapy for Neurodegenerative Diseases Product and Solutions
    • 2.6.4 Regenxbio Inc. Gene Therapy for Neurodegenerative Diseases Revenue, Gross Margin and Market Share (2018-2023)
    • 2.6.5 Regenxbio Inc. Recent Developments and Future Plans
  • 2.7 Sarepta Therapeutics
    • 2.7.1 Sarepta Therapeutics Details
    • 2.7.2 Sarepta Therapeutics Major Business
    • 2.7.3 Sarepta Therapeutics Gene Therapy for Neurodegenerative Diseases Product and Solutions
    • 2.7.4 Sarepta Therapeutics Gene Therapy for Neurodegenerative Diseases Revenue, Gross Margin and Market Share (2018-2023)
    • 2.7.5 Sarepta Therapeutics Recent Developments and Future Plans
  • 2.8 Gensight Biologics
    • 2.8.1 Gensight Biologics Details
    • 2.8.2 Gensight Biologics Major Business
    • 2.8.3 Gensight Biologics Gene Therapy for Neurodegenerative Diseases Product and Solutions
    • 2.8.4 Gensight Biologics Gene Therapy for Neurodegenerative Diseases Revenue, Gross Margin and Market Share (2018-2023)
    • 2.8.5 Gensight Biologics Recent Developments and Future Plans
  • 2.9 Krystal Biotech
    • 2.9.1 Krystal Biotech Details
    • 2.9.2 Krystal Biotech Major Business
    • 2.9.3 Krystal Biotech Gene Therapy for Neurodegenerative Diseases Product and Solutions
    • 2.9.4 Krystal Biotech Gene Therapy for Neurodegenerative Diseases Revenue, Gross Margin and Market Share (2018-2023)
    • 2.9.5 Krystal Biotech Recent Developments and Future Plans
  • 2.10 Avexis
    • 2.10.1 Avexis Details
    • 2.10.2 Avexis Major Business
    • 2.10.3 Avexis Gene Therapy for Neurodegenerative Diseases Product and Solutions
    • 2.10.4 Avexis Gene Therapy for Neurodegenerative Diseases Revenue, Gross Margin and Market Share (2018-2023)
    • 2.10.5 Avexis Recent Developments and Future Plans

3 Market Competition, by Players

  • 3.1 Global Gene Therapy for Neurodegenerative Diseases Revenue and Share by Players (2018-2023)
  • 3.2 Market Share Analysis (2022)
    • 3.2.1 Market Share of Gene Therapy for Neurodegenerative Diseases by Company Revenue
    • 3.2.2 Top 3 Gene Therapy for Neurodegenerative Diseases Players Market Share in 2022
    • 3.2.3 Top 6 Gene Therapy for Neurodegenerative Diseases Players Market Share in 2022
  • 3.3 Gene Therapy for Neurodegenerative Diseases Market: Overall Company Footprint Analysis
    • 3.3.1 Gene Therapy for Neurodegenerative Diseases Market: Region Footprint
    • 3.3.2 Gene Therapy for Neurodegenerative Diseases Market: Company Product Type Footprint
    • 3.3.3 Gene Therapy for Neurodegenerative Diseases Market: Company Product Application Footprint
  • 3.4 New Market Entrants and Barriers to Market Entry
  • 3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

  • 4.1 Global Gene Therapy for Neurodegenerative Diseases Consumption Value and Market Share by Type (2018-2023)
  • 4.2 Global Gene Therapy for Neurodegenerative Diseases Market Forecast by Type (2024-2029)

5 Market Size Segment by Application

  • 5.1 Global Gene Therapy for Neurodegenerative Diseases Consumption Value Market Share by Application (2018-2023)
  • 5.2 Global Gene Therapy for Neurodegenerative Diseases Market Forecast by Application (2024-2029)

6 North America

  • 6.1 North America Gene Therapy for Neurodegenerative Diseases Consumption Value by Type (2018-2029)
  • 6.2 North America Gene Therapy for Neurodegenerative Diseases Consumption Value by Application (2018-2029)
  • 6.3 North America Gene Therapy for Neurodegenerative Diseases Market Size by Country
    • 6.3.1 North America Gene Therapy for Neurodegenerative Diseases Consumption Value by Country (2018-2029)
    • 6.3.2 United States Gene Therapy for Neurodegenerative Diseases Market Size and Forecast (2018-2029)
    • 6.3.3 Canada Gene Therapy for Neurodegenerative Diseases Market Size and Forecast (2018-2029)
    • 6.3.4 Mexico Gene Therapy for Neurodegenerative Diseases Market Size and Forecast (2018-2029)

7 Europe

  • 7.1 Europe Gene Therapy for Neurodegenerative Diseases Consumption Value by Type (2018-2029)
  • 7.2 Europe Gene Therapy for Neurodegenerative Diseases Consumption Value by Application (2018-2029)
  • 7.3 Europe Gene Therapy for Neurodegenerative Diseases Market Size by Country
    • 7.3.1 Europe Gene Therapy for Neurodegenerative Diseases Consumption Value by Country (2018-2029)
    • 7.3.2 Germany Gene Therapy for Neurodegenerative Diseases Market Size and Forecast (2018-2029)
    • 7.3.3 France Gene Therapy for Neurodegenerative Diseases Market Size and Forecast (2018-2029)
    • 7.3.4 United Kingdom Gene Therapy for Neurodegenerative Diseases Market Size and Forecast (2018-2029)
    • 7.3.5 Russia Gene Therapy for Neurodegenerative Diseases Market Size and Forecast (2018-2029)
    • 7.3.6 Italy Gene Therapy for Neurodegenerative Diseases Market Size and Forecast (2018-2029)

8 Asia-Pacific

  • 8.1 Asia-Pacific Gene Therapy for Neurodegenerative Diseases Consumption Value by Type (2018-2029)
  • 8.2 Asia-Pacific Gene Therapy for Neurodegenerative Diseases Consumption Value by Application (2018-2029)
  • 8.3 Asia-Pacific Gene Therapy for Neurodegenerative Diseases Market Size by Region
    • 8.3.1 Asia-Pacific Gene Therapy for Neurodegenerative Diseases Consumption Value by Region (2018-2029)
    • 8.3.2 China Gene Therapy for Neurodegenerative Diseases Market Size and Forecast (2018-2029)
    • 8.3.3 Japan Gene Therapy for Neurodegenerative Diseases Market Size and Forecast (2018-2029)
    • 8.3.4 South Korea Gene Therapy for Neurodegenerative Diseases Market Size and Forecast (2018-2029)
    • 8.3.5 India Gene Therapy for Neurodegenerative Diseases Market Size and Forecast (2018-2029)
    • 8.3.6 Southeast Asia Gene Therapy for Neurodegenerative Diseases Market Size and Forecast (2018-2029)
    • 8.3.7 Australia Gene Therapy for Neurodegenerative Diseases Market Size and Forecast (2018-2029)

9 South America

  • 9.1 South America Gene Therapy for Neurodegenerative Diseases Consumption Value by Type (2018-2029)
  • 9.2 South America Gene Therapy for Neurodegenerative Diseases Consumption Value by Application (2018-2029)
  • 9.3 South America Gene Therapy for Neurodegenerative Diseases Market Size by Country
    • 9.3.1 South America Gene Therapy for Neurodegenerative Diseases Consumption Value by Country (2018-2029)
    • 9.3.2 Brazil Gene Therapy for Neurodegenerative Diseases Market Size and Forecast (2018-2029)
    • 9.3.3 Argentina Gene Therapy for Neurodegenerative Diseases Market Size and Forecast (2018-2029)

10 Middle East & Africa

  • 10.1 Middle East & Africa Gene Therapy for Neurodegenerative Diseases Consumption Value by Type (2018-2029)
  • 10.2 Middle East & Africa Gene Therapy for Neurodegenerative Diseases Consumption Value by Application (2018-2029)
  • 10.3 Middle East & Africa Gene Therapy for Neurodegenerative Diseases Market Size by Country
    • 10.3.1 Middle East & Africa Gene Therapy for Neurodegenerative Diseases Consumption Value by Country (2018-2029)
    • 10.3.2 Turkey Gene Therapy for Neurodegenerative Diseases Market Size and Forecast (2018-2029)
    • 10.3.3 Saudi Arabia Gene Therapy for Neurodegenerative Diseases Market Size and Forecast (2018-2029)
    • 10.3.4 UAE Gene Therapy for Neurodegenerative Diseases Market Size and Forecast (2018-2029)

11 Market Dynamics

  • 11.1 Gene Therapy for Neurodegenerative Diseases Market Drivers
  • 11.2 Gene Therapy for Neurodegenerative Diseases Market Restraints
  • 11.3 Gene Therapy for Neurodegenerative Diseases Trends Analysis
  • 11.4 Porters Five Forces Analysis
    • 11.4.1 Threat of New Entrants
    • 11.4.2 Bargaining Power of Suppliers
    • 11.4.3 Bargaining Power of Buyers
    • 11.4.4 Threat of Substitutes
    • 11.4.5 Competitive Rivalry

12 Industry Chain Analysis

  • 12.1 Gene Therapy for Neurodegenerative Diseases Industry Chain
  • 12.2 Gene Therapy for Neurodegenerative Diseases Upstream Analysis
  • 12.3 Gene Therapy for Neurodegenerative Diseases Midstream Analysis
  • 12.4 Gene Therapy for Neurodegenerative Diseases Downstream Analysis

13 Research Findings and Conclusion

    14 Appendix

    • 14.1 Methodology
    • 14.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on Gene Therapy for Neurodegenerative Diseases. Industry analysis & Market Report on Gene Therapy for Neurodegenerative Diseases is a syndicated market report, published as Global Gene Therapy for Neurodegenerative Diseases Market 2023 by Company, Regions, Type and Application, Forecast to 2029. It is complete Research Study and Industry Analysis of Gene Therapy for Neurodegenerative Diseases market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    		$3,480.00
    		$5,220.00
    		$6,960.00
    		2,780.52
    		4,170.78
    		5,561.04
    		3,232.92
    		4,849.38
    		6,465.84
    		537,868.80
    		806,803.20
    		1,075,737.60
    		290,580.00
    		435,870.00
    		581,160.00
    Credit card Logo
    Sample Question Discount Download PDF

    Related Reports

    Reason to Buy

    • Trusted By Leaders

      Top executives from leading companies purchase research reports from us. 

    • Shop With Confidence

      We assist you with all the pre-sales enquiries related to any report so that you can buy with confidence.

    • Customer Centric

      Need assistance related to your research requirements? We are just a phone call or an email away.

    • Personalized Solutions

      Our experienced research specialists are here to help you locate the right reports for your need.

    • Secure Checkout

      Shop without being worried about safety & security of your transactions.
      •

    Request for Sample of this report

    Reports and Markets

    mcafree

    Contact Us

    +1-352-353-0818 (US)

    info@reportsandmarkets.com

    Support

    EMAIL US

    Newsletter

    KEEP UP TO DATE ON ALL THE LATEST REPORTS


    maxmind_logo